September 24, 2020
Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses emerging therapies in myelofibrosis. Watch the interview.
Targeted Oncology: Treatment approaches become more individualized as field of myelofibrosis advances
September 21, 2020
In this interview, Ruben Mesa, MD, director of the Mays Cancer Center, shares highlights from his presentation on the role of JAK inhibitors in myelofibrosis during the first annual Texas Virtual MPN Workshop and Meeting. Read the story.
Congressional Hispanic Caucus Institute: Global Pandemics: Innovation for early detection and a coordinated response system
September 18, 2020
Ruben Mesa, MD, FACP, director of the Mays Cancer Center, was a guest on a panel during the Congressional Hispanic Caucus Institute’s 2020 Leadership Conference.
September 15, 2020
In this interview, Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses the emergence of JAK inhibitors in myelofibrosis. Watch the interview.
September 14, 2020
This news brief highlights the renewal of the Mays Cancer Center as an NCI-Designated Cancer Center. Read the story.
September 9, 2020
The American Society of Clinical Oncology (ASCO) has recognized Laura Tenner, MD, MPH, as one of ASCO’s 2019 Advocacy Champions at the Senator’s Club Level for her dedication to educating lawmakers on important policies that ensure patients have access to high quality cancer care. Her advocacy accomplishments include the ASCO Advocacy Summit on Capitol Hill, […]